Gene Therapy for HIV-1 Infection
The potential of gene-based therapy as a treatment of HIV/AIDS has been receiving considerable attention in recent years (for review see 1,2,3). Gene therapy is based on the notion that transfer of a therapeutic gene into target cells will render them resistant to HIV-1 replication. Infusion of cells protected by in vitro gene therapy into the patient may thus limit virus spread and delay disease progression.
KeywordsGene Therapy Umbilical Cord Blood Human Immunodeficiency Virus Replication Hammerhead Ribozyme Gene Delivery Vector
Unable to display preview. Download preview PDF.
- 1.Sarver N and Rossi JJ. Gene therapy for HIV-1 infection: progress and prospects. J NIH Res, 1993; 5: 63–67.Google Scholar
- 3.Bridges SH and Sarver N. Gene therapy and immune restoration for HIV disease. Lancet, 1995 (in press).Google Scholar
- 4.Kohn DB. The current status of gene therapy using hematopoietic stem cells. Current Opinions in Pediatrics 7 (1): 1995 (in Press).Google Scholar
- 10.Zhou C, Bahner I, Larson G, et al. Anti-HIV-1 hammerhead ribozymes transduced by retroviral vectors inhibit HIV-1 replication in human T lymphocytes. Gene (in press).Google Scholar
- 11.Cullen BR. Human immunodeficiency virus as a prototypic complex retrovirus. J Virol, 1991; 65: 1053 1056.Google Scholar
- 13.Malim MH, Freimuth WW, Liu J, et al. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J Exp Med, 1992; 176: 1197–1201.Google Scholar
- 22.Krall WJ, Challita PM, Perlmutter LS, et al. Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after mucine bone marrow transplantation. Blood, 1994; 83: 2373–2348.Google Scholar